openPR Logo
Press release

Opioid Induced Constipation (OIC) Drugs Sales Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017

11-01-2017 12:23 PM CET | Health & Medicine

Press release from: Opioid Induced Constipation (OIC) Drugs

Market Research Report

Market Research Report

Researchmoz added Most up-to-date research on "Opioid Induced Constipation (OIC) Drugs Sales Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017" to its huge collection of research reports.

In this report, the global Opioid Induced Constipation (OIC) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Opioid Induced Constipation (OIC) Drugs for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Opioid Induced Constipation (OIC) Drugs market competition by top manufacturers/players, with Opioid Induced Constipation (OIC) Drugs sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1343449

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

By Drug Type
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other

By Prescription Type
Generic and Branded Prescribed Drugs
Over The Counter Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Opioid Induced Constipation (OIC) Drugs for each application, including
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Table of Contents

Global Opioid Induced Constipation (OIC) Drugs Sales Market Report 2017
1 Opioid Induced Constipation (OIC) Drugs Market Overview
1.1 Product Overview and Scope of Opioid Induced Constipation (OIC) Drugs
1.2 Classification of Opioid Induced Constipation (OIC) Drugs by Product Category
1.2.1 Global Opioid Induced Constipation (OIC) Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Opioid Induced Constipation (OIC) Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Lubiprostone
1.2.4 Methyl Naltrexone Bromide
1.2.5 Naldemedine
1.2.6 Alvimopan

2 Global Opioid Induced Constipation (OIC) Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Opioid Induced Constipation (OIC) Drugs Market Competition by Players/Suppliers
2.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Opioid Induced Constipation (OIC) Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Opioid Induced Constipation (OIC) Drugs (Volume and Value) by Type
2.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Type (2012-2017)

Browse More Details @ https://www.researchmoz.us/global-opioid-induced-constipation-oic-drugs-sales-market-report-2017-report.html

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Opioid Induced Constipation (OIC) Drugs Sales Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 here

News-ID: 796623 • Views:

More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug